Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) anti-inflammatory compounds for
therapeutic target discovery and ALI treatment. Methods: 165 natural
Gareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) choice. Therefore, the possibility that lncRNAs could represent innovative
therapeutic agents or
targetsTaking into account the integrative nature of
therapeutic pedagogy, the question of using, choosing
Luo, W.,
Chen, X.,
Ye, L.,
Chen, X.,
Jia, W.,
Zhao, Y.,
Samorodov, A.V.,
Zhang, Y.,
Hu, X.,
Zhuang, F.,
Qian, J.,
Zheng, C.,
Liang, G.,
Wang, Y. (2021) -induced inflammation leading to renal dysfunction. We also show that KPF is a potential
therapeutic agent to reduce
Editorial: Cardio-Protection and Heart Repair: New Drugs,
Targets and Approaches
conducted. MiRNA
targets sites are a promising new area of research. In this study, we analyzed